Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.7B | 5.8B | 14.6B | 12.7B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.2B | 1.3B | 1.2B | 1.2B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 379M | 420M | 411M | 426M |
Other income expense | 52M | 59M | 72M | 88M |
Pretax income | 699M | 2.1B | 2.3B | 1.4B |
Tax provision | 76M | 406M | 274M | 252M |
Net income | 623M | 1.7B | 2.1B | 1.1B |
Basic EPS | 0.3 | — | 1.0 | 0.5 |
Diluted EPS | 0.3 | — | 1 | 0.5 |
Basic average shares | 2.4B | — | 2.5B | 2.5B |
Diluted average shares | 2.4B | — | 2.5B | 2.5B |
EBITDA | — | — | — | — |
Net income from continuing op. | 623M | 1.7B | 2.1B | 1.1B |
Minority interests | -66M | -22M | -131M | -39M |
Preferred stock dividends | 72M | 47M | 97M | 51M |